| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316273 | Pancreatology | 2016 | 7 Pages |
Abstract
Continuous infusion of esmolol, a selective beta-1 adrenergic blocker, improves outcome, reduces inflammatory responses and also offers lung and pancreas protective effects in SAP rats. This may offer novel therapeutic strategies in treating patients suffering from SAP.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Luyao Zhang, Yao Nie, Yishan Zheng, Lu Ke, Zhihui Tong, Weiqin Li, Jieshou Li,